Fever, leukopenia, and thrombocytopenia in a patient with acute lyme borreliosis were due to human granulocytic ehrlichiosis by Weber, Rainer et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 1998
Fever, leukopenia, and thrombocytopenia in a patient with acute lyme
borreliosis were due to human granulocytic ehrlichiosis
Weber, Rainer; Pusterla, Nicola; Loy, Monika; Lutz, Hans
DOI: https://doi.org/10.1086/517052
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-154679
Journal Article
Published Version
Originally published at:
Weber, Rainer; Pusterla, Nicola; Loy, Monika; Lutz, Hans (1998). Fever, leukopenia, and thrombocy-
topenia in a patient with acute lyme borreliosis were due to human granulocytic ehrlichiosis. Clinical
Infectious Diseases, 26(1):253-254.
DOI: https://doi.org/10.1086/517052
253CID 1998;26 (January) Correspondence
2. Chesney PJ, Bergdoll MS, Davis JP, Vergeront JM. The disease spectrum, borreliosis. The authors described a 22-year-old man who presented
epidemiology, and etiology of toxic-shock syndrome. Annu Rev Micro- with fever, headache, myalgia, arthralgia, conjunctivitis, fatigue, and
biol 1984;38:315–38. erythema migrans after he had been camping in forests in Slovenia.
3. Reingold AL, Hargrett NT, Dan BB, Shands KN, Strickland BY, Broome Because of the presence of leukopenia and thrombocytopenia, a diag-
CV. Nonmenstrual toxic shock syndrome. A review of 130 cases. Ann
nosis of ehrlichiosis was considered, but serological tests to detect
Intern Med 1982;96:871–4.
antibodies to Ehrlichia equi and Ehrlichia phagocytophila and micro-4. Kain KC, Schulzer M, Chow AW. Clinical spectrum of nonmenstrual toxic
scopic examination of blood smears were negative. However, theshock syndrome (TSS): comparison with menstrual TSS by multivariate
presence of antibodies to Borrelia burgdorferi was documented. Thediscriminant analyses. Clin Infect Dis 1993;16:100–6.
patient was treated with tetracyclines and recovered quickly.5. Cone LA, Woodard DR, Byrd RG, Schulz K, Kopp SM, Schlievt PM. A
recalcitrant, erythematous, desquamating disorder associated with toxin- Nadelman et al. [2] challenged the assertion of Gu¨nthard et al. [1,
producing staphylococci in patients with AIDS. J Infect Dis 1992;165: 3], arguing that a negative serology for E. equi does not exclude
638–43. coinfection with Ehrlichia and that unusual clinical manifestations or
6. Verbon A, Fisher CJ Jr. Severe recalcitrant erythematous desquamating laboratory findings following tick bites are not necessarily due to the
disorder associated with fatal recurrent toxic shock syndrome in a patient
protean manifestations of Lyme borreliosis but may be caused by
without AIDS. Clin Infect Dis 1997;24:1274–5.
coinfection with B. burgdorferi and the agents of human granulocytic7. Schlossberg D. A possible pathogenesis for recurrent toxic shock syndrome.
ehrlichiosis (HGE), babesiosis, or tick-borne encephalitis.Am J Obstet Gynecol 1981;141:348–9.
We recently had the opportunity to follow the patient of Gu¨n-8. Davis JP, Osterholm MT, Helms CM, et al. Tristate toxic-shock syndrome
thard almost 2 years after his illness. He had been completely healthystudy. II. Clinical and laboratory findings. J Infect Dis 1982;145:
441–8. since he was treated for acute Lyme disease. In addition, he clearly
remembered that he had been bitten by several ticks in Slovenia.
Reprints or correspondence: Dr. Annelies Verbon, Department of Internal Three stored serum samples (kindly provided by Dr. O. Pe´ter, Sion,
Medicine, F4-260, Academic Medical Center, Meibergdreef 9, 1105 AZ Am-
Switzerland) and one specimen obtained during the current follow-sterdam, the Netherlands.
up were examined for antibodies to E. phagocytophila by indirect
Clinical Infectious Diseases 1998;26:252–3
immunofluorescence, as previously described [4]. We found sero-q 1998 by The University of Chicago. All rights reserved.
1058–4838/98/2601–0083$03.00 conversion and reconversion of antibodies to E. phagocytophila, sug-
gesting that the patient had been coinfected with the agent of HGE
and with B. burgdorferi (table 1). It is well accepted that the causative
agent of HGE is immunologically closely related to E. phagocytophilaFever, Leukopenia, and Thrombocytopenia in a Patient
and E. equi, and thus these antigens (but not the Ehrlichia chaffeensiswith Acute Lyme Borreliosis Were Due to Human
antigen) are useful in serological testing for HGE [6].Granulocytic Ehrlichiosis
Ticks of the genus Ixodes (the likely vector of HGE) are prevalent
in Europe and are known to transmit Lyme borreliosis and the Euro-SIR—Gu¨nthard et al. [1] raised the question whether leukopenia,
thrombocytopenia, and hepatitis may be associated with acute Lyme pean tick-borne encephalitis virus. In addition, seroepidemiological
Table 1. Laboratory values for a 22-year-old man who was bitten by a tick in Slovenia.
No. of days after tick bite
Parameter 7 9 12 21 90 620
Leukocytes (1109/L) 2.2 3.3 ND 4.3 ND ND
Thrombocytes (1109/L) 98 140 ND 228 ND ND
C-reactive protein (mg/L)* 59 16 ND ND ND ND
Aspartate aminotransferase (U/L)† 96 61 ND 16 ND ND
Alanine aminotransferase (U/L)† 91 109 ND 51 ND ND
IgG and IgM antibodies to
Borrelia burgdorferi ‡ Negative ND Positive Positive ND ND
IgM antibodies to B. burgdorferi ‡ Borderline ND Positive Positive ND ND
Antibodies to European tick-borne
encephalitis virus Negative ND ND Negative Negative ND
Antibodies to Ehrlichia equi and
Ehrlichia phagocytophila ‡ Negative ND ND Negative Negative ND
Titer of antibodies to
E. phagocytophila§ 20 ND 80 ND 80 20
NOTE. ND  not done.
* Normal level, 10.
† Normal level, 40.
‡ Data are from [1,3].
§ Data are from methods previously described [4,5]; titers of 80 are considered negative.
254 Correspondence CID 1998;26 (January)
Referencesdata from Switzerland [7], Norway, the United Kingdom, and Sweden
have suggested that HGE may be prevalent in Europe. Investigators
1. Gu¨nthard HF, Pe´ter O, Gubler J. Leukopenia and thrombocytopenia in ain Slovenia recently provided serological and molecular evidence of
patient with early Lyme borreliosis. Clin Infect Dis 1996;22:1119–20.HGE in their country [8]. Furthermore, a newly discovered species
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[letter]. Clin Infect Dis 1997;24:1027–8.
HGE [9]. Thus, it can be hypothesized that HGE occurs in Europe,
3. Pe´ter P, Gubler J, Gu¨nthard HF. Reply [letter]. Clin Infect Dis 1997;24:
although there have not been any reports of microscopic detection of 1028–9.
the organism in humans. 4. Pusterla N, Wolfensberger C, Lutz H, Braun U. Serological testing on the
The methods for diagnosing HGE have yet to be improved. The occurence of bovine ehrlichiosis in the Cantons Zu¨rich, Schaffhausen,
clinical manifestation of ehrlichiosis is a nonspecific febrile illness. Thurgau, St. Gallen and Obwalden. Schweiz Arch Tierheilkd 1997 (in
The sensitivity of microscopic examination for detecting Ehrlichia in press).
5. Pusterla N, Wolfensberger C, Gerber-Bretscher R, Braun U, Lutz H. Com-granulocytes or monocytes is low [10], and molecular diagnosis is
parison of indirect immunofluorescence for Ehrlichia phagocytophilaavailable only in research laboratories. Serological tests to detect
and E. equi in horses. Equine Vet J 1998 (in press).antibodies to the agent of HGE are currently not standardized and
6. Dumler JS, Asanovich KM, Bakken JS, Richter P, Kimsey R, Madiganare not commercially available; furthermore, negative serological tests
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tophila, and human granulocytic Ehrlichia. J Clin Microbiol 1995;33:of Gu¨nthard et al. [1, 3] to detect antibodies reacting with E. equi
1098–103.
and E. phagocytophila on days 21 and 90 could be explained by a
7. Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulo-
somewhat lower diagnostic sensitivity of the tests used. We have cytic ehrlichiosis in Europe. Lancet 1995;346:782–3.
used an assay that has been extensively validated in 2,557 serum 8. Petrovec M, Furlan SL, Zupanc TA, et al. Human disease in Europe caused
samples from cattle [4], 1,645 serum samples from horses [5], and by a granulocytic Ehrlichia species. J Clin Microbiol 1997;35:1556–9.
in 1,515 human serum samples (N. Pusterla, unpublished data). 9. Pusterla N, Huder J, Wolfensberger C, Litschi B, Parvis A, Lutz H. Granu-
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inases [10], is crucial because it has major therapeutic implications.
HGE requires treatment with tetracyclines and does not respond
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